Emergent BioSolutions faces scrutiny in Congress for ruining Covid-19 vaccines and securing lucrative federal contracts. Executives will appear before some lawmakers who benefited from the company’s spending.
from NYT > Top Stories https://ift.tt/3eYUfjL
https://ift.tt/eA8V8J
No comments:
Post a Comment